Public Profile

Braintree Laboratories, Inc.

Braintree Laboratories, Inc., commonly referred to as Braintree Labs, is a leading player in the biotechnology industry, headquartered in the United States. Founded in 2010, the company has established itself as a pioneer in developing innovative solutions for the pharmaceutical and healthcare sectors. With a strong operational presence across North America and Europe, Braintree Labs focuses on advanced drug delivery systems and biopharmaceutical manufacturing. The company’s core offerings include cutting-edge formulations and customised manufacturing services that set them apart in a competitive market. Braintree Labs is recognised for its commitment to quality and regulatory compliance, achieving significant milestones such as ISO certification and partnerships with major pharmaceutical firms. With a reputation for excellence, Braintree Laboratories continues to drive advancements in biotechnology, positioning itself as a trusted partner in the industry.

DitchCarbon Score

How does Braintree Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Braintree Laboratories, Inc.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Braintree Laboratories, Inc.'s reported carbon emissions

Braintree Laboratories, Inc., headquartered in the US, currently does not have available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may still be engaged in broader industry initiatives aimed at sustainability and reducing environmental impact. As the climate landscape evolves, it is essential for organisations like Braintree Laboratories to establish clear commitments and measurable targets to contribute effectively to global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Braintree Laboratories, Inc.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Braintree Laboratories, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Braintree Laboratories, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Astra Zeneca

GB
Chemicals nec
Updated 3 days ago

Takeda

JP
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Cumberland Pharmaceuticals Inc.

US
Chemicals nec
Updated 14 days ago

RedHill Biopharma Ltd.

IL
Health and social work services (85)
Updated 14 days ago

Nektar Therapeutics

US
Chemicals nec
Updated 21 days ago

Ironwood Pharmaceuticals, Inc.

US
Chemicals nec
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers